1 recruiting, 1 unknown. 2 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 2 | Recruiting 1, Unknown 1 |
Follow Memantine Oral Tablet: new trials by email Literature Review of Memantine Oral Tablet trials Research Report on Memantine Oral Tablet
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Evaluation of Memantine in the Preservation of Memory and Neurocognition Following CSI Memantine Oral Tablet - Neurocognitive Dysfunction | Phase 3 | Recruiting | Tata Memorial Centre | 101 | 2024-02-22 | 2025-04-09 |
| Memantine for Refractory OCD Patients Memantine Oral Tablet, Placebo - Obsessive-Compulsive Disorder | Phase 3 | Unknown | University of Roma La Sapienza | 20 | 2021-09-01 | 2021-08-20 |
Cognition Disorders (1) · Obsessive-Compulsive Disorder (1)
Tata Memorial Centre (1) · University of Roma La Sapienza (1)
India (1)
PMID 10465680, PMID 16490414, PMID 23063327, PMID 23525525, PMID 29100251, PMID 37166948, PMID 41673604